MetaCap

BriaCell Therapeutics Insider Trades

NASDAQ: BCTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.06-0.105 (-3.32%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

BriaCell Therapeutics insider activity

No BriaCell Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Lustig Marc (Director) buying 902,935 shares at $2.22 on May 14, 2024. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BCTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BCTX insider transactions

BriaCell Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
May 14, 2024Lustig MarcDirectorBuy902,935$2.00MForm 4
Dec 28, 2022Bondarenko JamiesonChairmanBuy28,000$128.24KForm 4
Dec 20, 2022Bondarenko JamiesonDirectorBuy22,000$117.70KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related